Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
For people at risk of depressive relapse, mindfulness-based cognitive therapy (MBCT) has an additive benefit to usual care (H. F. Coelho, P. H. Canter, & E. Ernst, 2007). This study asked if, among patients with recurrent depression who are treated with antidepressant medication (ADM), MBCT is comparable to treatment with maintenance ADM (m-ADM) in (a) depressive relapse prevention, (b) key secondary outcomes, and (c) cost effectiveness. The study design was a parallel 2-group randomized controlled trial comparing those on m-ADM (N = 62) with those receiving MBCT plus support to taper/discontinue antidepressants (N = 61). Relapse/recurrence rates over 15-month follow-ups in MBCT were 47%, compared with 60% in the m-ADM group (hazard ratio = 0.63; 95% confidence interval: 0.39 to 1.04). MBCT was more effective than m-ADM in reducing residual depressive symptoms and psychiatric comorbidity and in improving quality of life in the physical and psychological domains. There was no difference in average annual cost between the 2 groups. Rates of ADM usage in the MBCT group was significantly reduced, and 46 patients (75%) completely discontinued their ADM. For patients treated with ADM, MBCT may provide an alternative approach for relapse prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We judged one study as having unclear risk as the authors used last observation carried forward (LOCF) as the imputation method for missing data for secondary outcomes, and we considered this to be an inappropriate method in this context (see discussion) (Kuyken 2008).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Kuyken 2008
In the citing paper
“Ten (16%) participants in the continuation group withdrew from the trial due to discontinuation of antidepressants.”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Kuyken 2008
In the citing paper
“Kuyken 2008 reported that at the end of the six-month window for tapering, 46 of 61 (75%) participants in the MBCT arm of the trial discontinued their medication.”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Kuyken 2008
In the citing paper
“In the further six-month follow-up period, rates of antidepressant usage between the two groups continued to be highly significantly different (P < 0.0001), although no data on antidepressant use in both groups were provided.”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Kuyken 2008
In the citing paper
“Data show no differences between discontinuation and continuation in the physical domain (MD -0.22, 95% CI -2.16 to 1.73; 455 participants, 2 studies; I = 65%; random-effects model)”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Kuyken 2008
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
(1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00112-k · Cited by 7,643
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686
Mindfulness training as a clinical intervention: a conceptual and empirical review
Baer, R. A. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg015 · Cited by 4,577
Mindfulness training as a clinical intervention: A conceptual and empirical review.
Baer, R. A. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy/bpg015 · Cited by 4,576
(2001) · Cited by 3,666
Self-citationPrevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Self-citation(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607 · cited 1×
“Future trials will be able to base themselves on extant effect sizes and examine outstanding questions such as external validity in increasingly real-world settings, the costs of training MBCT therapists, the efficacy of augmenting m-ADM treatment with MBCT, and comparisons with other psychosocial approaches to relaps…”
BackgroundMa, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Self-citationThree-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 2×
“First, given that m-ADM over at least 2 years is recommended to prevent relapse/ recurrence (Geddes et al., 2003; NICE, 2004) and many patients express a preference for an alternative approach, it is important to establish whether MBCT enables patients to taper/discontinue ADM.”
BackgroundHirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Kessler, R. C., Zhao, S., Blazer, D. G., & Swartz, M. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00056-6 · Cited by 790
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772 · cited 1×
“Despite the skewed nature of cost data, this approach is recommended to enable inferences to be made about the arithmetic mean ( Thompson & Barber, 2000 ), a more meaningful summary statistic for costs than is the median or geometric mean.”
BackgroundPrevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735
(2004) · Cited by 673
Epidemiology of depression in primary care
Katon, W., & Schulberg, H. (1992) · General Hospital Psychiatry · doi:10.1016/0163-8343(92)90094-q · Cited by 664
The Clinical Course of Unipolar Major Depressive Disorders
Judd, L. L. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230015002 · Cited by 460
Segal, Z. V., Teasdale, J. D., Williams, J. M., & Gemar, M. C. (2002) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.320 · Cited by 432 · cited 6×
“The total adherence scale scores in the trial (M 29.1; SD 4.69) were at least comparable to those reported in the psychometric evaluation of this scale ( Segal, Teasdale, et al., 2002 ) and indicate acceptable adherence to protocol.”
BackgroundMethodResultInfluentialSelf-citationHow Should Remission From Depression Be Defined? The Depressed Patient’s Perspective
Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, N., & Boerescu, D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.148 · Cited by 431
Patients' preferences in the treatment of depressive disorder in primary care
van Schaik, D. J. F., Klijn, A. F. J., van Hout, H. P. J., van Marwijk, H. W. J., Beekman, A. T. F., de Haan, M., & van Dyck, R. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.12.001 · Cited by 428
PHARMACEUTICAL SOCIETY OF GREAT BRITAIN.
Hill, A. (1930) · The Lancet · doi:10.1016/s0140-6736(00)86391-6 · Cited by 376
A practical guide for calculating indirect costs of disease
Koopmanschap, M. A., & Rutten, F. F. H. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610050-00003 · Cited by 358
Bower, P., Byford, S., Sibbald, B., Ward, E., King, M., Lloyd, M., & Gabbay, M. (2000) · BMJ · doi:10.1136/bmj.321.7273.1389 · Cited by 345
Self-citationHollon, S. D., Muñoz, R. F., Barlow, D. H., Beardslee, W. R., Bell, C. C., Bernal, G., Clarke, G. N., Franciosi, L. P., Kazdin, A. E., Kohn, L., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01384-7 · Cited by 328
Simon, G. E., Katon, W. J., VonKorff, M., Unützer, J., Lin, E. H. B., Walker, E. A., Bush, T., Rutter, C., & Ludman, E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1638 · Cited by 328
Continuity of Antidepressant Treatment for Adults With Depression in the United States
Ballenger, J. C. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70480-8 · Cited by 313
The Mindful Way through Depression: Freeing Yourself from Chronic Unhappiness
Williams, J. M. G. (2012) · Cited by 309
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299
Continuation drug therapy for major depressive episodes: how long should it be maintained?
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.18 · Cited by 295
A Randomized Trial of Relapse Prevention of Depression in Primary Care
Katon, W., Rutter, C., Ludman, E. J., Von Korff, M., Lin, E., Simon, G., Bush, T., Walker, E., & Unützer, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.241 · Cited by 295
Long-term Outcome of Episodes of Major Depression: Clinical and Public Health Significance
Keller, M. B. (1984) · JAMA · doi:10.1001/jama.252.6.788 · Cited by 295
Bockting, C. L. H., DELTA Study Group, Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.4.647 · Cited by 249
Lau, M. A., Segal, Z. V., & Williams, J. M. G. (2004) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.03.003 · Cited by 232
Mindfulness-based cognitive therapy: evaluating current evidence and informing future research
Coelho, H. F., Canter, P. H., & Ernst, E. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.6.1000 · Cited by 227
Some methodological and statistical issues in the study of change processes in psychotherapy
Laurenceau, J.-P., Hayes, A. M., & Feldman, G. C. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.01.007 · Cited by 225
Baldwin, S. A., Murray, D. M., & Shadish, W. R. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.924 · Cited by 209
Evidence of cost-effective treatments for depression: a systematic review
Barrett, B. M., Byford, S., & Knapp, M. R. J. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.10.003 · Cited by 134
Self-citationCost-effectiveness of a program to prevent depression relapse in primary care
Simon, G. E., Von Korff, M., Ludman, E. J., Katon, W. J., Rutter, C., Unützer, J., Lin, E. H. B., Bush, T., & Walker, E. (2002) · Medical Care · doi:10.1097/00005650-200210000-00011 · Cited by 115
Cost-Effectiveness of Collaborative Care for Depression in a Primary Care Veteran Population
Liu, C., Hedrick, S. C., Chaney, E. F., Heagerty, P. J., Felker, B. L., Hasenberg, N., Fihn, S. D., & Katon, W. J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.5.698 · Cited by 99
Byford, S., Knapp, M. R. J., GREENSHIELDS, J., Ukoumunne, O. C., JONES, V., THOMPSON, S., Tyrer, P. J., Schmidt, U. H., Davidson, K., & ( POPMACT GROUP) (2003) · Psychological Medicine · doi:10.1017/s0033291703008183 · Cited by 95
Self-citationCooper, C., Bebbington, P., King, M., Brugha, T. S., Meltzer, H., Bhugra, D., & Jenkins, R. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00974.x · Cited by 93
Judd, L. L., Paulus, M. P., & Zeller, P. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.764 · Cited by 83
Goldberg, D. P. (2000) · Academic Psychiatry · doi:10.1176/appi.ap.24.3.119 · Cited by 36
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20
Self-citationUnder/over‐recruitment to mental health trials
White, K., Holden, E., Byng, R., Mullan, E., & Kuyken, W. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01061.x · Cited by 10
Self-citation
Cited by
Effects of mindfulness on psychological health: A review of empirical studies
Keng, S.-L., Smoski, M. J., & Robins, C. J. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.006 · Cited by 2,687
“Subsequent studies of MBCT and depression relapse selected only patients with three or more episodes and have replicated the effect of MBCT on reduced relapse rates (Godfrin & van Heeringen, 2010; Kuyken et al., 2008) or prolonged time to relapse (Bondolfi et al.”
BackgroundMeditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis
Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13018 · Cited by 2,380
Mindfulness practice leads to increases in regional brain gray matter density
Hölzel, B. K., Carmody, J., Vangel, M., Congleton, C., Yerramsetti, S. M., Gard, T., & Lazar, S. W. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2010.08.006 · Cited by 1,914
Gu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.01.006 · Cited by 1,712
“…in comparison to control conditions, including anxiety (Green & Bieling, 2012; Hofmann, Sawyer, Witt, & Oh, 2010), risk of relapse for depression (Kuyken et al., 2008; Teasdale et al., 2000), current depressive symptoms (Strauss, Cavanagh, Oliver, & Pettman, 2014), stress (Chiesa & Serretti,…”
BackgroundInfluentialComorbidity: a network perspective
Cramer, A. O. J., Waldorp, L. J., van der Maas, H. L. J., & Borsboom, D. (2010) · Behavioral and Brain Sciences · doi:10.1017/s0140525x09991567 · Cited by 1,575
Metadata
- Authors
- Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., & Teasdale, J. D.
- Affiliations
- University of Exeter (GB)
- King's College London (GB)
- Venue
- Journal of Consulting and Clinical Psychology
- Published
- 2008
- Volume
- 76
- Issue
- 6
- Pages
- 966-978
- ISSN
- 0022-006X (ISSN-L)
- 1939-2117
- OpenAlex
- W2097229930
- Semantic Scholar
- 11aafd35e28b530b0c5f29e6f5516ae79cad39e7
- Cited by
- 770
- References
- 57
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 23 · 2023: 25 · 2022: 26 · 2021: 45 · 2020: 58 · 2019: 33 · 2018: 36 · 2017: 39 · 2016: 53 · 2015: 63 · 2014: 50 · 2013: 56 · 2012: 71
- FWCI
- 54.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Consulting and Clinical Psychology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Medical Research Council (TP 72167)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- mindfulness-based cognitive therapy, recurrent depression, depressive relapse prevention, antidepressant maintenance, antidepressant tapering, antidepressant discontinuation, cost-effectiveness, residual depressive symptoms, psychiatric comorbidity, quality of life
- MeSH terms
- Adult, Aged, Antidepressive Agents, Awareness, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Patient Compliance, Cognitive Behavioral Therapy, Diagnostic and Statistical Manual of Mental Disorders, Secondary Prevention, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.